Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

Clinical trial NCT05893225 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05893225
Sponsor: University Hospital, Antwerp
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis Primary Progressive Multiple Sclerosis Secondary-progressive Multiple Sclerosis

Start date: 2023-11-23
Primary completion: 2027-02-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.